<form id="xpvpb"><nobr id="xpvpb"><nobr id="xpvpb"></nobr></nobr></form>

                          <em id="xpvpb"><form id="xpvpb"><th id="xpvpb"></th></form></em>
                          <address id="xpvpb"><nobr id="xpvpb"></nobr></address><form id="xpvpb"></form>

                                    <form id="xpvpb"></form>


                                          <em id="xpvpb"><form id="xpvpb"></form></em>
                                          National free service hotline:4008365133

                                          Company profile

                                          Your current position:Home > Company profile

                                          Suzhou Hong Sen Pharmaceutical Co., Ltd. was established on April 17, 2009, production address: Jiangsu Taicang Port Development Zone, petrochemical zone GCL Road on the 12th, registered capital of 98 million yuan, 2.3 million yuan in fixed assets, covers an area of 4.3 million square meters, construction area of 2.5 million square meters.

                                          Company's main products include pharmaceutical intermediates, pharmaceutical raw materials (including sterile APIs), frozen dried powder injection, small volume injection, oral solid dosage forms (tablets and capsules) and inhalation solution. Currently has 17 APIs and small capacity injection workshop, tablets, hard capsule agent through the national GMP certification, with an annual output of: 350 tons of raw material medicine (fine baked package), 1 billion ampoules of small volume injections, 15 million tablets, 1 million capsules agent, product coverage of antitumor, antiviral, central nervous, anti infective, cardiovascular, digestive, antipyretic analgesic class.

                                          Company's existing drug approval number 160 (21 APIs, 89 tablet, capsule 8, small volume injections 42), also company technical personnel of the institute through continuous research and innovation, improve the quality of existing products and production efficiency, has won a number of national patents, and received the title of national high and new technology enterprise in 2014. At present through cooperative research and development, is committed in the registration and declaration of new antiviral, respiratory system, nervous system, digestive system, cardiovascular drugs, and project application of narcotic drugs and psychotropic substances for the record, at present already products received clinical approval.

                                          The company currently targets:

                                          1:and strive to become a unique anti viral, cardiovascular, respiratory, digestive system and psychiatric and other specialized drug production enterprises,

                                          2:gradually become the National Narcotics and psychotropic substances designated production enterprises and clinical essential drug varieties designated production enterprises,

                                          3:the use of existing products, and constantly improve the respiratory system all dosage forms, including solid oral, injection, freeze-dried injection, aerosol inhalation solution, spray, and so on.

                                          The company has long been committed to doing good for the Chinese people to use good medicine for our national health and safety of the use of a force.

                                          <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>